Format

Send to

Choose Destination
Vaccine. 2005 Mar 18;23(17-18):2060-5.

Plasmid maintenance systems suitable for GMO-based bacterial vaccines.

Author information

1
Berna Biotech Ltd., Bacterial Vaccine Research, Rehhagstr. 79, CH-3018 Berne, Switzerland. simone.spreng@bernabiotech.com

Abstract

Live carrier-based bacterial vaccines represent a vaccine strategy that offers exceptional flexibility. Commensal or attenuated strains of pathogenic bacteria can be used as live carriers to present foreign antigens from unrelated pathogens to the immune system, with the aim of eliciting protective immune responses. As for oral immunisation, such an approach obviates the usual loss of antigen integrity observed during gastrointestinal passage and allows the delivery of a sufficient antigen dose to the mucosal immune system. Antibiotic and antibiotic-resistance genes have traditionally been used for the maintenance of recombinant plasmid vectors in bacteria used for biotechnological purposes. However, their continued use may appear undesirable in the field of live carrier-based vaccine development. This review focuses on strategies to omit antibiotic resistance determinants in live bacterial vaccines and discusses several balanced lethal-plasmid stabilisation systems with respect to maintenance of plasmid inheritance and antigenicity of plasmid-encoded antigen in vivo.

PMID:
15755571
DOI:
10.1016/j.vaccine.2005.01.009
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center